Related Experiment Videos
[Prevention of respiratory syncytial virus infections]
1U.O. di Pneumologia, Istituto G. Gaslini, Genova, Italy. giovannirossi@ospedale-gaslini.ge.it
Minerva Pediatrica
|May 1, 2002
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The impact of age on serum allergen-specific IgE to inhaled molecular components.
Allergologia et immunopathologia·2017
Allergen-specific IgE to food molecular components and age: From early childhood to adulthood.
Allergologia et immunopathologia·2016
TNF-alpha, IL-4R-alpha and IL-4 polymorphisms in mild to severe asthma from Italian Caucasians.
International journal of immunopathology and pharmacology·2013
DNA bacterial load in children with bacteremic pneumococcal community-acquired pneumonia.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2013
IgE in childhood asthma: relevance of demographic characteristics and polysensitisation.
Archives of disease in childhood·2010
Modulation by flunisolide of tumor necrosis factor-alpha-induced stimulation of airway epithelial cell activities related to eosinophil inflammation.
The Journal of asthma : official journal of the Association for the Care of Asthma·2010
A new approach to the diagnosis of short stature.
Minerva pediatrica·2020
Kounis Syndrome: a pediatric perspective.
Minerva pediatrica·2020
Tall stature in children and adolescents.
Minerva pediatrica·2020
Precocious puberty.
Minerva pediatrica·2020
Medical AI across Data Regimes to Promote Proactive Health.
Health data science·2026
Kidney Health for all: Caring for People, Protecting the Planet.
Canadian journal of kidney health and disease·2026
Advancing Community Engagement in Healthcare in Rural British Columbia: A Gap Analysis to Improve Community Involvement in Healthcare Planning.
Healthcare policy = Politiques de sante·2026
Cost-effectiveness analysis of pneumococcal vaccination of at-risk and high-risk adults aged 18-64 years in Switzerland using PCV21.
Journal of medical economics·2026